CXCR1 and breast cancer: The results highlight the efficacy of the prepared Cc-AgNPs against E. coli and P. aeruginosa bacteria and show that they have peculiar antiproliferative properties against the breast cancer cell line MCF7, suggesting that they may play a promising role in future antimicrobial and anticancer therapeutics.